Please Wait

Applying Filters...

Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Cefepime Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

18 API Suppliers, 9 USDMF, 1 CEP/COS, 8 JDMF, 4 EU WC, 15 KDMF, 7 NDC API, 3 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

43 FDF Dossiers, 27 FDA Orange Book, 2 Europe, 3 Canada, 8 South Africa, 3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Faran Shimi Pharmaceutical, 1 Pfanstiehl, 1 Actylis, 1 Pluviaendo, 4 Roquette

EXCIPIENTS BY APPLICATIONS

4 Parenteral, 2 Fillers, Diluents & Binders, 1 Thickeners and Stabilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 5 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 Regulatory FDF Prices

2 Regulatory FDF Prices

MARKET PLACE

7 APIs

7 APIs

PATENTS & EXCLUSIVITIES

24 Health Canada Patents

24 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
28/03/2025	Fresenius Kabi Anti-Infectives	Italy	FRESENIUS KABI IPSUM S.R.L. Cassina de’ Pecchi IT	CEP 2022-460 - Rev 00	Cefepime dihydrochloride monohydrate, Sterile, process 2	2023-09-13	Valid	Chemical		2126

Contact us
to update this info

Cefepime Hydrochloride

Cefepime Hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

18 API Suppliers

9 USDMF

1 CEP/COS

8 JDMF

4 EU WC

15 KDMF

7 NDC API

3 Listed Suppliers

$ API Reference Price

FINISHED DOSAGE FORMULATIONS

43 FDF Dossiers

27 FDA Orange Book

2 Europe

3 Canada

8 South Africa

3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Faran Shimi Pharmaceutical

1 Pfanstiehl

1 Actylis

1 Pluviaendo

4 Roquette

EXCIPIENTS BY APPLICATIONS

4 Parenteral

2 Fillers, Diluents & Binders

1 Thickeners and Stabilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

5 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 Regulatory FDF Prices

MARKET PLACE

7 APIs

PATENTS & EXCLUSIVITIES

24 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP

1 Others

Filters

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 500MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons